Literature DB >> 8554968

Do telomerase antagonists represent a novel anti-cancer strategy?

E K Parkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8554968      PMCID： PMC2074295          DOI： 10.1038/bjc.1996.1

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  46 in total

Review 1.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

Authors:  R A Weinberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

2.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

3.  Tumor suppressor genes: the puzzle and the promise.

Authors:  R Sager
Journal:  Science       Date:  1989-12-15       Impact factor: 47.728

Review 4.  Structure and function of telomeres.

Authors:  V A Zakian
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

5.  Telomere-telomere recombination provides an express pathway for telomere acquisition.

Authors:  S S Wang; V A Zakian
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Dynamics of telomere length variation in Tetrahymena thermophila.

Authors:  D D Larson; E A Spangler; E H Blackburn
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

8.  Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens.

Authors:  R F Newbold; R W Overell; J R Connell
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

9.  Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: possible involvement of chromosome 1 in tumour progression.

Authors:  C Paraskeva; S Finerty; S Powell
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

10.  Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene.

Authors:  R F Newbold; R W Overell
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962
View more
  2 in total

1.  Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.

Authors:  A M Burger; M C Bibby; J A Double
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.

Authors:  Xiaohong Liu; Hazuki Takahashi; Yoko Harada; Tsukasa Ogawara; Yuta Ogimura; Yoshiyuku Mizushina; Mineo Saneyoshi; Toyofumi Yamaguchi
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.